Hyperpara |
|
|
Author |
Date |
Comments |
Messa |
98 |
81 pts, those with high PTH a year post tx had hx longer
time on HD and higher pre-tx PTH levels; some relationship to
VDR genotypes seen |
D'Alessandro |
89 |
between '81&'87 tx in 1025 pts, 819 survived, 1.8% had
PTX mean time 18 mo post tx; 29% had hypercalcemia, of those
25% persisted longer than 7 yrs |
Leunissen |
86 |
2 pts with posttransplant high PTH treated with po pamidronate
and improved, PTH also fell |
Vezzoli |
86 |
xs study of pts 4 yrs post tx found high iCa in 66% |
Cundy |
83 |
pros obs of 100 pts for 2 yrs, 36% developed high calcium,
mean onset 148 days, assoc with longer time on dialysis and high
PTH |
Memmos |
82 |
report their series of PTX |
McCarron |
80 |
PTH-calcium curves in tx pts show higher baseline but similar
shape, suggeting hyperplasia as mechanism |
David |
73 |
reviewed 64 pts who had successful renal tx, 34% hypercalcemia,
86% within the first year, persisited in 8 of them, all with
high PTH. Also more pre-tx metastatic calcif. |
Alfrey |
68 |
17 pts, hypercalcemia in 9, resolved, bone xrays got better |
Aluminum |
|
|
Briner |
95 |
20 pts, Al 48% to 11% 2 yrs post tx |
David-Neto |
93 |
11 pts with Al, all improved, necrosis in 6, bxs showed decreased
osteoid and al surface, increased bone formation |
Davenport |
93 |
38 pts followed prospectively who didnt need transfusions;
aluminum decreased and hemoglobin increased; Hb incrase greater
in those not given al antacids. |
Betolone |
93 |
20 pts aluminum in bone 63 to 36 mcg/kg; bxs decreased osteoid
(but none adynamic in the first place) |
Dahl |
92 |
Al decreased in bxs pre and post tx in PTX as well as non-PTX
pts. Poor reasoning about relation of Al to PTX! |
Nordal |
92 |
pros bxs in 55 pts; 10/55 had hypercalcemia; no AVN on standard
xrays, cortical thick. decreased, BV same, BFR increased, Al
stain decr |
Piraino |
88 |
case report - got better post tx |
Nordal |
88 |
suggest Al helps rejection, bad statistics |
AVN |
|
|
Lausten |
98 |
xs study 750 pts, AVN 11.2% in high-dose steroids, average
26 mo p tx, and only 5% in low-dose steroids average 20 mo |
Holman |
95 |
J Rheumatol from UW - find |
Siddiqui |
93 |
some asymptomatic pts with pos MRI resolve; pros study of
72 pts x2yrs, 10 hips nl scan, abn MRI which resolved in 6, no
sx; 13 scan abn, MRI nl, resolved in 8; 3 pts had sx and both
studies pos |
Fordyce |
93 |
32 pts, 3 had pos MRI but no sx, one later got sx |
Churchill |
91 |
29 pts with stage 3 or 4 AVN, mean onset of sx 33 mo post
tx, by 3 yrs 60% of hips needed surgery, by 5 yrs 80% |
Kopecky |
91 |
104 pts, pros x 24 mo, 10 developed MRI pos, 4 of them developed
pain. Xrays pos in the 4 with sx. |
Patton |
88 |
444 pts, 16% got AVN sx, related to steroid dose |
Landmann |
87 |
AVN in 15/174 pre cyclosporin, 1/96 post |
Spencer |
83 |
bone scans showed AVN in 8/42 pts, 7 became symptomatic |
Nixon |
79 |
AVN in 14 of 181 within 4 yrs. |
Ibels |
78 |
40/184, 21% had symptomatic AVN, 15 of them had surgery |
Amyloid |
|
|
Tan |
96 |
KI article - find |
Barden |
95 |
14 pts tx after ?10 yrs HD, articular sx better in 10, still
had amyloid deposits and subchondral bone erosions |
Jadoul |
89 |
amyloid pain improved post tx, maybe due to steroids, no
new cysts for 4 yrs but no regression either |